Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 01 OCTOBER 2019

Life Sciences Patent Network North America 2019

HGF Law
Explore more from HGF Law

HGF Partner Iain Armstrong will be attending and speaking at LSPN North America 2019 on 16th October. The session will cover ‘CAR–T and other immunotherapies'

United StatesIntellectual Property
HGF Limited
HGF Limited
Author LinkedIn connections

HGF Partner Iain Armstrong will be attending and speaking at LSPN North America 2019 on 16th October. The session will cover 'CAR–T and other immunotherapies'.

Immunotherapies, such as CAR-T cells, are a hugely promising therapeutic area, both in terms of clinical benefits and potential market size. The treatments have proven remarkably effective in achieving positive outcomes in forms of cancer that are otherwise difficult to treat. As a result, their clinical use has recently been approved in both the US and Europe.

The potential for this market has already spurred tens of billion of dollars in acquisition activity by those wishing to enter the field, and investment in this area is continuing to grow. The expanding market means patenting is becoming more important.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

UMG v. DistroKid: When AI Becomes A Consumer Protection Issue

Universal Music Group's lawsuit against DistroKid raises a critical question about AI disclosure in consumer markets: when does the use of artificial intelligence become material information that must be disclosed to consumers? The case centers on allegations that DistroKid distributed mass-generated AI music while creating the impression it was created by legitimate human artists, potentially violating existing consumer protection laws even without specific AI disclosure requirements.
United StatesIntellectual Property
Frankfurt Kurnit Klein & Selz PC
Frankfurt Kurnit Klein & Selz PC
Article

PTAB/USPTO Update - October 2026

The USPTO has released new templates and guidance for AIA trial proceedings, announced key appointments including a Chief AI Officer, and published updated procedures for patent applications and subject matter eligibility declarations. Director Squires delivered multiple addresses emphasizing the constitutional importance of intellectual property rights while the agency expanded its community engagement efforts and international collaboration through WIPO's Global IP Assignment Platform pilot program.
United StatesIntellectual Property
WilmerHale
WilmerHale
Article

The Trademark Scam Field Guide: Look-Alike Filing Sites, Fake USPTO Notices, And How To Get Out If You’ve Been Caught

A business decides to file a trademark. Someone on the team searches for a familiar online legal-services brand, clicks the first result, and lands on a site with a similar-sounding name, a polished design, five-star reviews, and a low flat fee. The application gets filed. Months later the business learns the “service” was not who they thought it was, the filing was signed by someone with no authority to sign it, and the USPTO has suspended the application along with hundreds or thousands of others from the same shop.
United StatesIntellectual Property
Harness IP
Harness IP
Article

Is This Real? Navigating AI Impersonation Under New And Existing Laws

Is this AI-generated, or is it real? As generative AI tools have become increasingly capable of creating realistic images, videos, and audio, they have also made it easier to impersonate real people without their consent. In response, states are increasingly adopting laws that impose civil and criminal liability for certain AI-generated content that replicates an individual’s identity, likeness, voice, or other personal attributes.
United StatesIntellectual Property
Wiley Rein
Wiley Rein
Article

High Court Clarifies The Limits Of Copyright Claims Against Online Marketplaces

The UK High Court has delivered a landmark ruling on online marketplace liability, dismissing Shein's copyright infringement claims against Temu and clarifying when platforms can be held responsible for third-party content. The judgment examines the boundaries of copyright ownership in complex supply chains and establishes important precedents for how marketplace operators should respond to infringement allegations.
United KingdomIntellectual Property
HGF Law
HGF Law
Article

UPC CoA Confirms Jurisdiction Over Pending European Patent Application

The UPC Court of Appeal has confirmed that the Unified Patent Court can exercise jurisdiction over European patent applications, provided they are granted before the defendant files their statement of defence. This landmark decision means patent holders may now be locked into the UPC system even before their patents are officially granted, fundamentally changing the strategic timing considerations for opting out of UPC jurisdiction.
United KingdomIntellectual Property
HGF Law
HGF Law
Article

Patenting Performance: Protecting The Science Behind A Personal Best

Nomio, a broccoli-based sports supplement gaining popularity among endurance athletes, has secured patent protection for its innovative use of sulforaphane to enhance exercise performance and treat metabolic conditions. This analysis explores how the company leveraged university research to protect both therapeutic and non-therapeutic applications of their simple three-ingredient formula, demonstrating that even products with common ingredients can achieve robust patent protection through novel use claims.
United KingdomIntellectual Property
HGF Law
HGF Law
Article

UK Patents Court Reinforces The UK Threshold For Plausibility

The UK Patents Court has upheld Novartis' patent and SPC protecting Entresto, its blockbuster heart failure treatment combining valsartan and sacubitril, rejecting all validity challenges from generic manufacturer Accord Healthcare. The judgment provides crucial guidance on plausibility requirements where experimental data have been generated but not fully disclosed in the patent specification, clarifying when qualitative disclosure of positive results suffices without detailed numerical data.
United KingdomIntellectual Property
HGF Law
HGF Law
Article

UPC CoA Confirms “gold Standard” For Added Matter In Sibio v Abbott

The Court of Appeal of the Unified Patent Court recently issued a decision examining whether omitting an elastomeric sealing member from a patent claim constitutes added matter, applying the EPO's "gold standard" test while emphasizing the importance of functional and structural relationships between features. The ruling provides crucial insight into how the UPC approaches intermediate generalizations and whether its methodology differs from the notoriously strict EPO practice on added subject-matter.
LuxembourgIntellectual Property
HGF Law
HGF Law
Article

Protecting The AI Drug Discovery Ecosystem: Building An IP Stack Around Targets, Molecules And Medicines

As computational biology and artificial intelligence reshape drug discovery, pharmaceutical companies face a critical challenge: how to protect not just the final therapeutic compound, but the entire ecosystem of datasets, models, and biological insights that enabled its creation. This article examines the evolving intellectual property landscape where 90% of clinical candidates still fail, yet the tools predicting their success are becoming as valuable as the medicines themselves.
United KingdomIntellectual Property
HGF Law
HGF Law
Article

Trade Mark Changes In Jersey, And Why They Might Affect You

Jersey has completely overhauled its trade mark system, establishing its own Intellectual Property Office and abolishing the previous UK re-registration requirement. The new framework aligns closely with UK trade mark law while enabling Jersey to participate directly in the Madrid System for international registrations. These changes, effective August 1, 2026, include automatic cloning of existing UK designations into Jersey rights and signal further IP modernization ahead.
JerseyIntellectual Property
HGF Law
HGF Law
Article

Cleaning Up The Laundry: Innovations In Mitigating Microplastic Contamination From Man-made Fabrics

Microplastic contamination from synthetic textiles poses a growing environmental threat, with fibres from man-made fabrics entering water systems through washing machine effluent. As countries like France mandate microplastic filters in washing machines and the EU implements new wastewater treatment rules, innovative companies are developing filtration technologies and novel removal methods to combat this pervasive pollution problem.
United KingdomEnvironment
HGF Law
HGF Law